Reversal of glucose-induced inhibition of insulin release by dibutyryl cyclic AMP

Exp Clin Endocrinol. 1989 May;93(2-3):307-12. doi: 10.1055/s-0029-1210873.

Abstract

Insulin release in response to glucose was measured after culture of islets from ob/obmice in a medium deficient in Ca2+. When present at a concentration of 6 mmol/l, glucose inhibited, insulin release. After activation of the alpha2-adrenergic receptors by 1 mumol/l clonidine also 20 mmol/l glucose became inhibitory. The inhibitory action of glucose on insulin release disappeared in the presence of 1 mmol/l dibutyryl cyclic AMP. Raising the glucose concentration from 3 to 20 mmol/l resulted in increased cytoplasmic Ca2+ after an initial depression. Whereas clonidine removed the Ca2+ increase, this phase was partly restored after simultaneous addition of dibutyryl cyclic AMP. It is concluded that cyclic AMP plays a major role in controlling the balance between the stimulatory and inhibitory components in the glucose action on insulin release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology*
  • Calcium / analysis
  • Calcium / metabolism
  • Clonidine / pharmacology
  • Cytoplasm / analysis
  • Cytoplasm / metabolism
  • Dose-Response Relationship, Drug
  • Glucose / pharmacology*
  • Insulin / metabolism*
  • Mice
  • Mice, Obese

Substances

  • Insulin
  • Bucladesine
  • Glucose
  • Clonidine
  • Calcium